- RAO RM, Kumar N, P SP, Rao MJ, et al
Convergent genetic and structural parameters of cardiovascular disease related insights of post-acute COVID-19.
Biochem Biophys Res Commun. 2026;831:154319.
PubMed Abstract available - LIU C, Yan Z, Tao Z, Yang W, et al
C5a-C5aR1 axis activation drives neutrophil extracellular trap formation in SARS-CoV-2 N protein-mediated acute kidney injury.
Biochem Biophys Res Commun. 2026;831:154305.
PubMed Abstract available - AEBISCHER A, Gunther A, Piesche R, Wernike K, et al
Development of a multi-species luciferase-based double-antigen ELISA for the detection of antibodies against influenza A virus H5 clade 2.3.4.4b.
J Clin Microbiol. 2026 Aug 13:e0190725. doi: 10.1128/jcm.01907.
PubMed Abstract available - LOZANO-MONTALBA L, Denis Z, Courgnaud V, Moreno-Garcia J, et al
Glycosphingolipids are essential entry factors for non-influenza orthomyxoviruses.
J Gen Virol. 2026;107.
PubMed Abstract available - MCKERNAN KE, Cephus JY, Kuehnle SN, Henriquez-Pilier E, et al
Deficiency in circulating T cells in four core genotypes mice with Sry translocation.
J Immunol. 2026;215:vkag207.
PubMed Abstract available - HANSEN CL, Shaikh N, Naeger S, Torcel-Pagnon L, et al
Hospitalizations and deaths from major respiratory viruses in the US: An ensemble time series modeling study, 2016-2025.
J Infect. 2026;93:106811.
PubMed Abstract available - VINK E, Murphy ME, Gunson R, MacConnachie A, et al
Respiratory viral detection in adult severe acute respiratory infection post-COVID-19 pandemic: implications for antimicrobial stewardship.
J Infect. 2026;93:106805.
PubMed Abstract available - RAN J, Zhu L, Ning M, Zhang W, et al
Age-associated impairment of humoral and cellular immune responses to SARS-CoV-2 in a large community cohort with hybrid immunity.
J Infect. 2026 Jul 1:106803. doi: 10.1016/j.jinf.2026.106803.
PubMed Abstract available - KONG M, Gao HX, Song XD, Yang GJ, et al
Convergent neutralizing antibodies to SARS-CoV-2 variants over 2.5 years after BA.5/BF.7 breakthrough infection.
J Infect. 2026 Jun 18:106799. doi: 10.1016/j.jinf.2026.106799.
PubMed Abstract available - ATUKORALE VN, Kwong JC, Hernandez A, Moineddin R, et al
Factors associated with severe health outcomes among community-dwelling older adults hospitalized with respiratory syncytial virus.
J Infect. 2026;93:106797.
PubMed Abstract available - DONG S, Li M, Huo D, Zhao H, et al
Impact of EV-A71 vaccination and non-pharmaceutical interventions on hand, foot, and mouth disease: A 14-year interrupted time series analysis.
J Infect. 2026;93:106795.
PubMed Abstract available - TRUONG T, Radin JM, Li L, Ordonez-Mena JM, et al
Burden and economic impact of RSV hospitalisations among English adults, 2023/24.
J Infect. 2026;93:106792.
PubMed Abstract available - WANG X, Yin J, Xu B, Guanhua X, et al
Clinical epidemiological characteristics of hospitalized pediatric Mycoplasma pneumoniae pneumonia in China.
J Infect. 2026 Jun 10:106793. doi: 10.1016/j.jinf.2026.106793.
PubMed Abstract available - PULIT-PENALOZA J, Belser JA, Brock N, Kieran TJ, et al
Risk assessment of avian influenza A(H5N5) virus from the first human case using the ferret model.
J Virol. 2026 Aug 11:e0085626. doi: 10.1128/jvi.00856.
PubMed Abstract available - LIU Z, Zhang L, Jiang M
Efficacy and Safety of an mRNA Seasonal Influenza Vaccine in Adults.
N Engl J Med. 2026;395:724.
PubMed - LOCQUET M, Dogne JM
Efficacy and Safety of an mRNA Seasonal Influenza Vaccine in Adults.
N Engl J Med. 2026;395:724-725.
PubMed - HUANG G, Das R, Wilson E
Efficacy and Safety of an mRNA Seasonal Influenza Vaccine in Adults. Reply.
N Engl J Med. 2026;395:725-726.
PubMed
Recommendations for Prevention and Control of Influenza in Children, 2026-2027: Policy Statement.
Pediatrics. 2026 Aug 10. doi: 10.1542/peds.2026-078778.
PubMed Abstract available
Recommendations for Prevention and Control of Influenza in Children, 2026-2027: Technical Report.
Pediatrics. 2026 Aug 10. doi: 10.1542/peds.2026-078779.
PubMed Abstract available- FORNA A, Damodaran L, Gunning CE, Rahimi P, et al
Alignment-free prediction of cross-reactivity in influenza A (H3N2) anticipates antigenic drift.
PLoS Comput Biol. 2026;22:e1014628.
PubMed Abstract available - MURPHY C, Cheng SMS, Mak L, So HC, et al
Diagnostic agreement between Rhinoswabs and joint nose and throat swabs for the detection of influenza and SARS-CoV-2 among symptomatic ambulatory patients in Hong Kong.
PLoS One. 2026;21:e0355869.
PubMed Abstract available - KILDAY D, Korvink M, Tatum D, Cao Z, et al
Association between COVID-19 by variant period and delivery-related outcomes in the United States.
PLoS One. 2026;21:e0355223.
PubMed Abstract available - TAMAKI S, Kawashima R, Uematsu T, Kawakami F, et al
Eosinophil-associated intestinal immune responses following SARS-CoV-2 infection in K18-hACE2 mice.
PLoS One. 2026;21:e0355607.
PubMed Abstract available - PIETAN L, Phillippi E, Melo M, El-Shanti H, et al
Genome-wide machine learning analysis of anosmia and ageusia with COVID-19.
PLoS One. 2026;21:e0355832.
PubMed Abstract available - CHEN PY, Dang LH, Hung SH
The association between meteorological factors and influenza incidence in Taiwan: Regional heterogeneity and subtropical climate variability.
PLoS One. 2026;21:e0355559.
PubMed Abstract available - PARK S, Kwon JA, Kim HS, Choi Y, et al
Socioeconomic differences in influenza vaccination coverage by government financial support status: A population-based study in Korea.
PLoS One. 2026;21:e0353764.
PubMed Abstract available - ALSHAHRANI A, Reddy RS, Gular K, Kakaraparthi VN, et al
Postural control and trunk mobility impairments in adults with long COVID: A cross-sectional study using computerized posturography and clinical biomechanical tools.
PLoS One. 2026;21:e0354593.
PubMed Abstract available - TUT G, Lancaster T, Sylla P, Bone D, et al
High rates of SARS-CoV-2 reinfection in residents of long term care facilities despite robust spike-specific immunity following serial vaccination.
PLoS One. 2026;21:e0354079.
PubMed Abstract available - KIM Y, Lee J, Park J
Concentration of hospital utilization in the capital area among elderly inpatients from non-capital regions in South Korea: Before and during the COVID-19 pandemic.
PLoS One. 2026;21:e0336744.
PubMed Abstract available - FREIRE SF, Shimizu IS, Lima CAS, Adhikari NKJ, et al
The association between resource availability and knowledge, attitudes, and practice about protective ventilation among ICU directors - A nationwide cross-sectional survey.
PLoS One. 2026;21:e0355354.
PubMed Abstract available - KARADUMAN E, Toprak N, Cevik A, Erail S, et al
Factors associated with fear and coping strategies during pandemic in female university students: The moderator role of physical activity and infection status.
PLoS One. 2026;21:e0355544.
PubMed Abstract available - IRIEMENAM NC, Osawe S, Akanbi OA, Akinmulero O, et al
High prevalence of SARS-CoV-2 antibodies among frontline healthcare workers during the COVID-19 pandemic in three states of Nigeria from August to December 2022.
PLoS One. 2026;21:e0354606.
PubMed Abstract available - DIAZ TOVAR JS, Dos Reis FP, Moriyama LT, Pego-Fernandes PM, et al
Anatomy-resolved digital twin framework for personalized light dosimetry in lung therapies.
Proc Natl Acad Sci U S A. 2026;123:e2612370123.
PubMed Abstract available - GEBREMARIAM AG, Genie M, Le H, Regan A, et al
Vaccine uptake in the context of mandate announcement and removal: Evidence from Europe and North America.
Vaccine. 2026;88:128825.
PubMed Abstract available - FAVRE G, Pfund A, Gerbier E, Anselem O, et al
Acceptability and preferences regarding RSV immunisation during pregnancy: a cross-sectional study in diverse global settings.
Vaccine. 2026;88:128783.
PubMed Abstract available - CARAZO S, Skowronski DM, Sauvageau C, Talbot D, et al
2024/25 end-of-season KP.2 vaccine effectiveness against COVID-19 hospitalization in older adults: a test-negative study in Quebec, Canada.
Vaccine. 2026;88:128786.
PubMed Abstract available - EBRAHIMI N, de Whalley P, Kanji N, Ramasamy MN, et al
ChAdOx1 nCoV-19 coronavirus vaccine: Long-term safety and immunological responses.
Vaccine. 2026;88:128951.
PubMed Abstract available - DALEXIS RD, Beogo I, Xu Y, Muray M, et al
Post-COVID-19 pandemic inequities in routine childhood immunization in Canada: racial disparities in uptake of polio, meningococcal conjugate, and varicella vaccines.
Vaccine. 2026;88:128931.
PubMed Abstract available - HUSSAIN HS, Yousafzai MT, Iqbal J, Aslam ZM, et al
Immunogenicity and reactogenicity of fractional vs. full booster doses of COVID-19 vaccines: A non-inferiority, randomized, double-blind, phase IV clinical trial in Pakistan.
Vaccine. 2026;88:128918.
PubMed Abstract available - YOON SK, Phillips AL, Battan-Wraith S, Thiese MS, et al
Real-world effectiveness and safety of protein-based and mRNA COVID-19 vaccines (BEEHIVE trial).
Vaccine. 2026;88:128954.
PubMed Abstract available - DIARRA M, Li S, Gaur S, Greenberg P, et al
Understanding parent motivation for participating in the Pfizer COVID-19 vaccine trial.
Vaccine. 2026;88:128960.
PubMed Abstract available - BELL S, Chantler T, Passanante A, Pryce J, et al
Maternal respiratory syncytial virus (RSV) vaccine perceptions amongst pregnant women and mothers of infants and toddlers in England: a qualitative study.
Vaccine. 2026;88:128955.
PubMed Abstract available - MAEDA H, Igarashi A, Mitsui S, Suzuki K, et al
Interim analysis of effectiveness of JN.1-adapted conventional and self-amplifying mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infection in adults aged >/=60 years, Japan, October 2024-April 2025.
Vaccine. 2026;88:128964.
PubMed Abstract available - BARASA L, Onyango G
The institutional roots of vaccine uptake and hesitancy: evidence from Africa.
Vaccine. 2026;88:128980.
PubMed Abstract available - LI J, Wang Z, Gong Y
Country-level immunization recovery and DTP1 no-dose proxy burden after COVID-19: a descriptive ecological analysis of WUENIC, 2010-2024.
Vaccine. 2026;88:128973.
PubMed Abstract available - KIM T, Wang X, Rajtmajer S, Harden JJ, et al
Elected officials' online anti-vaccination statements respond to online engagement.
Vaccine. 2026;88:128901.
PubMed Abstract available - C M, Dymock M, Flanagan KL, Plebanski M, et al
The Platform trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity and safety of seven licensed COVID-19 vaccines delivered as fifth dose or subsequent boosters in immunocompetent adults.
Vaccine. 2026;88:128970.
PubMed Abstract available - DE PADUA MC, Antunes MOB, Stein RT, Pinto LA, et al
Effectiveness of BNT162B2 and CoronaVac vaccines in reducing COVID-19 severity among children aged 3-4 years in Brazil.
Vaccine. 2026;88:128974.
PubMed Abstract available - TAY CJX, Koh CWT, Ooi JSG, Li HE, et al
Over-induction of innate immune responses suppresses T cell response to mRNA SARS-CoV-2 vaccination.
Vaccine. 2026;88:128983.
PubMed Abstract available - RAFIZADEH A, Wijekoon D, Aung ET, Aguirre I, et al
Influenza vaccination uptake among people living with HIV in Melbourne, 2015-2025: a repeated cross-sectional study.
Vaccine. 2026;90:129038.
PubMed Abstract available - SAITOH A, Takaku M
Partner awareness and support for maternal RSV vaccination: a paired survey of pregnant women and co-residing partners in Japan.
Vaccine. 2026;88:128946.
PubMed Abstract available - PAUL KK, Newall AT
The cost of respiratory syncytial virus (RSV) across all ages to the Australian healthcare system.
Vaccine. 2026;88:128922.
PubMed Abstract available - AUNG TN, Muyindike W, Hoeppner SS, Nanfuka V, et al
COVID-19 vaccination among people with HIV in Uganda: lessons from a high-risk group with high vaccine uptake for the next pandemic.
Vaccine. 2026;88:128912.
PubMed Abstract available - HENSLEY AA, Jiles KA, Edwards S, Clinchard C, et al
Characteristics of successful and unsuccessful strategies to increase vaccine intention and improve vaccine uptake for U.S. adult populations in the Affordable Care Act era (2010-2025): a systematic review and meta-regression.
Vaccine. 2026;88:128910.
PubMed Abstract available - MCCONEGHY KW, Wilker EH, DeVone F, Skov B, et al
Vaccine effectiveness of mRNA-1345 against RSV-associated hospitalization and medically attended acute respiratory illness among US veterans, 2025-2026.
Vaccine. 2026;88:128882.
PubMed Abstract available - NAKANO T, Iwata S, Oishi K, Iguchi E, et al
Immunogenicity and safety of a SARS-CoV-2 recombinant vaccine S-268024 booster vaccination versus NVX-CoV2373: Interim results from a phase 3, multicenter, randomized, observer-blind, active-controlled study.
Vaccine. 2026;88:128871.
PubMed Abstract available - MALTEZOU HC, Borg M, Botelho-Nevers E, Brantsaeter AB, et al
Vaccination policies for healthcare personnel in Europe, 2026.
Vaccine. 2026;88:128839.
PubMed Abstract available - MYERS TR, Zauche LH, Marquez PL, McCullum I, et al
V-safe: Summary of findings reported after COVID-19 vaccination to a US CDC active safety surveillance system through June 2023.
Vaccine. 2026;88:128725.
PubMed Abstract available - PRAT-AYMERICH C, Yeghiazaryan L, Pathirana RD, Gautier V, et al
A prematurely terminated phase 2, randomised trial to evaluate immunogenicity and reactogenicity of a single versus two-dose primary vaccination regimen of the mRNA vaccine BNT162b2 in previously SARS-CoV-2 infected children 5-11 years old (CoVacc tri
Vaccine. 2026;88:128769.
PubMed Abstract available - SINGER D, La EM, Dubois de Gennes C, Graham J, et al
Public health impact and cost-effectiveness of adjuvanted RSVPreF3 vaccination among US adults aged 18-49 years at increased risk for severe RSV disease.
Vaccine. 2026;88:128770.
PubMed Abstract available - GONDWE KW, Hearst MO, Mbutuka HR, Khwepeya M, et al
Factors associated with COVID-19 vaccine acceptance among refugee women at Dzaleka refugee camp in Malawi.
Vaccine. 2026;88:128862.
PubMed Abstract available - LIU Z, Wang X, Hu Y, Duan X, et al
Burden of infection and hospitalization from respiratory syncytial virus-associated acute lower respiratory tract infections in Chinese children: Modeling of national, regional, and provincial estimates.
Vaccine. 2026;88:128875.
PubMed Abstract available - MORIO R, Takazono T, Morimoto S, Ashizawa N, et al
Comparison of immunogenicity of mRNA and protein subunit SARS-CoV-2 vaccines in dialysis patients: a multicenter study.
Vaccine. 2026;88:128861.
PubMed Abstract available - TORKAMAN-ASADI F, Bakhtiari S, Safarzadeh M, Riahi-Rad Z, et al
Clinical outcomes among SARS-CoV-2 omicron-infected adults according to prior infection and vaccination history in Iran: A retrospective registry-based study.
Vaccine. 2026;88:128868.
PubMed Abstract available - FLEMING JA, Colistro V, Knudson S, Colomar M, et al
Timing and frequency of antenatal care visits in relation to maternal respiratory syncytial virus vaccine opportunities in four Latin American countries.
Vaccine. 2026;88:128854.
PubMed Abstract available - ASAGA PM, Kroeger A, Yako A, Makpo J, et al
Global misinformation, local consequences: conspiracy theory endorsement and a graded association with COVID-19 vaccine refusal across Nigeria.
Vaccine. 2026;88:128827.
PubMed Abstract available - RICKE IJ, Ward C, Spaulding AB, Sherwood NE, et al
Caregiver COVID-19 vaccine status and its influence on pediatric vaccination decisions in a US cohort.
Vaccine. 2026;88:128847.
PubMed Abstract available - RAZZAGHI H, Garacci E, Kahn KE, Meghani M, et al
Maternal and infant immunizations for respiratory diseases, United States, may 2025.
Vaccine. 2026;88:128823.
PubMed Abstract available - BYRNE AMP, James J, Thomas SS, Warren CJ, et al
Impact of prior low-pathogenicity avian influenza H7N7 exposure on susceptibility and protection against homologous high-pathogenicity avian influenza H7N7 challenge in chickens.
Virology. 2026;624:111047.
PubMed Abstract available
Biochem Biophys Res Commun
No comments:
Post a Comment